Can the CROSS protocol be safely implemented in real world scenario with broader eligibility criteria? Experience from a tertiary care centre in India

BACKGROUND: The Chemoradiotherapy for Oesophageal Cancer Followed by Surgery Study (CROSS) trial established a new benchmark in the management of oesophageal cancer with neoadjuvant chemoradiation followed by surgery with a marked benefit for squamous cell carcinomas (SCCs). We evaluate if the CROSS...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhattacharyya, Tapesh, Arunsingh, Moses, Chakraborty, Santam, Harilal, Vishnu, Sasidharan, Rohit, Saha, Saheli, Thambudorai, Robin, Roy, Bipradas, Banerjee, Sudeep, Roy, Paromita, Ray, Soumendranath, Mallick, Indranil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2021
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580591/
https://www.ncbi.nlm.nih.gov/pubmed/34824614
http://dx.doi.org/10.3332/ecancer.2021.1291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580591/
https://www.ncbi.nlm.nih.gov/pubmed/34824614
http://dx.doi.org/10.3332/ecancer.2021.1291

Ejemplares similares